|
Direct upload of microarray results provides optimal data interpretation
CARY, NC, AND REDWOOD CITY, CA –
February 19, 2007 – SAS, the leader
in business intelligence, and Ingenuity Systems
today announced a partnership aimed at streamlining
the discovery of important biological connections
from high-throughput microarray experiments.
Integration between JMP Genomics software
from SAS and Ingenuity Pathways Analysis (IPA)
provides users the capability to upload the
results of microarray analysis workflows directly
into IPA for rapid and reliable interpretation
of their experimental data within a biological
context.
JMP Genomics combines the visualization and
analytic flexibility of the SAS® and JMP
statistical platforms with prebuilt analytics
for large genetics, microarray and spectral
data sets. “JMP Genomics is used by
biologists and biostatisticians to identify
and explore statistically relevant patterns
in large expression data sets,” explained
Shannon Conners, JMP Genomics Product Manager.
“We are pleased to offer our mutual
users a smooth transition from high-quality
statistical discovery to biological discovery
through integration with the Ingenuity Pathways
Analysis solution.”
“By integrating Ingenuity Pathway Analysis
with JMP Genomics, our joint customers will
have a robust and reliable solution for analyzing
and interpreting their data,” said Tuan
Nguyen, Vice President, Partner and Professional
Services of Ingenuity Systems. “The
integration supports a unified workflow that
enables users to seamlessly analyze data and
generate results that are biologically relevant
so they can make informed research decisions.
Ingenuity Systems has the leading database
in the industry for biological information,
and through IPA, JMP Genomics users can benefit
from this information to uncover mechanisms
of action, predict potential toxicities and
identify candidate biomarkers.”
JMP Genomics is developed by JMP,
a business unit of SAS. JMP Genomics 2.0.4,
released in December 2006, includes the IPA
direct-upload capability. Future versions
of JMP Genomics, including JMP Genomics 3.0,
scheduled for release in mid-2007, also will
incorporate the direct-upload capability.
JMP Genomics is Affymetrix® GeneChip-compatible™
for expression, exon expression and SNP analysis.
About Ingenuity Pathways Analysis
Ingenuity Pathways Analysis is a software
application that enables researchers to model,
analyze and understand the complex biological
systems at the core of life science research.
IPA is deployed in all major pharmaceutical
companies and hundreds of biotechnology companies
and academic institutions globally. It supports
analysis of all high-throughput analysis platforms
and is used in virtually all areas of drug
discovery and development, from target identification
and validation to biomarkers, predictive toxicology
and pharmacogenomics. Ingenuity Pathways Analysis
is available as a Web-delivered, hosted or
deployed solution. Fully functional complimentary
trials are available at www.ingenuity.com/trial.
About Ingenuity Systems®
Ingenuity enables researchers to model, analyze
and understand complex biological systems
foundational to human health and disease.
The Ingenuity products include pathways analysis
software and knowledge bases for biologists
and bioinformaticians, and enterprise knowledge
management infrastructure, content and services
for leading pharmaceutical and biotech companies.
Ingenuity was founded in 1998 and is headquartered
in Redwood City, CA, with offices in Germany,
Switzerland, France, the United Kingdom and
Japan. www.ingenuity.com.
Contact:
Heidi
Bullock
Director, Marketing
Ingenuity Systems
650.381.5150
Holli Dickson
Account Supervisor
Porter Novelli Life Sciences
858.527.3495
>
View as PDF 
|
